biosimilar Archives - Express Pharma

Biocon Biologics receives FDA approval for biosimilar YESINTEK

Biocon Biologics report explores pathways to increase biosimilar adoption in low- and middle-income countries

USFDA grants approval of Bkemv to Amgen

USV and Biogenomics launches Insuquick

Biocon Biologics successfully integrates acquired biosimilars business across 120 countries

USV, Biogenomics launch INSUQUICK, biosimilar Insulin Aspart for diabetes treatment

EMA accepts Intas Pharma’s MAA for DMB-3115

Dr Reddy’s completes Phase I study of DRL_TC, a tocilizumab biosimilar candidate

Biocon Biologics, Viatris get EC approval for biosimilar Bevacizumab

USFDA defers action on BLA for Avastin biosimilar, notifies Biocon Biologics, Mylan